420 related articles for article (PubMed ID: 26000799)
1. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Bittencourt CE; Ha JP; Maitta RW
PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK
Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.
Tuncer HH; Oster RA; Huang ST; Marques MB
Transfusion; 2007 Jan; 47(1):107-14. PubMed ID: 17207238
[TBL] [Abstract][Full Text] [Related]
5. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
[TBL] [Abstract][Full Text] [Related]
6. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
Bell WR; Braine HG; Ness PM; Kickler TS
N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
[TBL] [Abstract][Full Text] [Related]
7. Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy.
Egan JA; Hay SN; Brecher ME
J Clin Apher; 2004; 19(4):165-7. PubMed ID: 15597353
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study.
Zhang W; Shi H; Ren H; Shen PY; Pan XX; Li X; Chen YX; Xu YW; Chen XN; Zhu P; Chen N
Nephron Clin Pract; 2009; 112(3):c177-83. PubMed ID: 19439988
[TBL] [Abstract][Full Text] [Related]
9. Primary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011.
Dahlan R; Sontrop JM; Li L; Ghadieh O; Clark WF
Am J Nephrol; 2015; 41(6):429-37. PubMed ID: 26183258
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients.
Levandovsky M; Harvey D; Lara P; Wun T
J Hematol Oncol; 2008 Dec; 1():23. PubMed ID: 19046460
[TBL] [Abstract][Full Text] [Related]
11. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Lara PN; Coe TL; Zhou H; Fernando L; Holland PV; Wun T
Am J Med; 1999 Dec; 107(6):573-9. PubMed ID: 10625026
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of thrombotic microangiopathies].
Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
14. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
[TBL] [Abstract][Full Text] [Related]
15. Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state.
Hay SN; Egan JA; Millward PA; Bandarenko N; Brecher ME
Ther Apher Dial; 2006 Jun; 10(3):237-41. PubMed ID: 16817787
[TBL] [Abstract][Full Text] [Related]
16. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
Som S; Deford CC; Kaiser ML; Terrell DR; Kremer Hovinga JA; Lämmle B; George JN; Vesely SK
Transfusion; 2012 Dec; 52(12):2525-32; quiz 2524. PubMed ID: 22501034
[TBL] [Abstract][Full Text] [Related]
17. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007.
George JN
Kidney Int Suppl; 2009 Feb; (112):S52-4. PubMed ID: 19180137
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak.
Dundas S; Murphy J; Soutar RL; Jones GA; Hutchinson SJ; Todd WT
Lancet; 1999 Oct; 354(9187):1327-30. PubMed ID: 10533860
[TBL] [Abstract][Full Text] [Related]
19. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
[TBL] [Abstract][Full Text] [Related]
20. TTP/HUS and prognosis: the syndrome and the disease(s).
Forzley BR; Clark WF
Kidney Int Suppl; 2009 Feb; (112):S59-61. PubMed ID: 19180139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
